News & Articles

DNA/RNA Shield – DirectDetect reagent eliminates RNA extraction for rapid deployment of COVID-19 tests

The new machine learning tool could help healthcare workers to quickly screen and direct the flow of COVID-19 patients arriving at hospitals

Gain insights on topics from point-of-care blood testing, cardiac troponin and biomarker discovery to clinical QC and more

A study by researchers at Oxford University found that we are amidst the biggest decrease in life expectancy since WWII

Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more

Discover innovative POC technology designed to meet today’s emergency care needs and inform effective management of cardiac patients

Offering user-friendly, efficient specimen collection, the Combo Swab is expected to dramatically improve COVID-19 testing efficiency

Watch this on-demand webinar to learn about the cell avidity technology advancing CAR-T cell therapy research

Prof. Akiko Iwasaki explores the differences in the immune responses of COVID-19 patients with moderate and severe disease

A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine

Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy

Adults who have received a double vaccination are 47% less likely to have long COVID

Research led by Queen’s University Belfast has shown that dogs can predict epileptic seizures, offering a warning sign to owners that has the potential to save lives

Gain insights on topics from pleural fluid analysis, CRISPR technologies, trace element analysis in food products & more

Industry experts discuss the role of artificial intelligence in the fight against COVID-19, the lessons learned and its future promise in healthcare

Keep up to date with the latest technologies and techniques advancing clinical diagnostics

The CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify esophageal cancer patients for treatment with KEYTRUDA (pembrolizumab)

Gain insights on topics from point-of-care cardiac troponin, CRISPR editing efficiency, targeted biomarker measurements for precision medicine & more

Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond